Literature DB >> 88610

Oral clonidine as a growth hormone stimulation test.

I Gil-Ad, E Topper, Z Laron.   

Abstract

A single oral dose of 0.15 mg/m2 of clonidine was given to eighteen healthy children and adolescents and to seven patients with hypopituitarism. In healthy subjects there was a pronounced increase in plasma growth hormone from 4.9 +/- 1.3 ng/ml (+/- SEM) to 34.4 +/- 4.5 ng/ml. In the patients with hypopituitarism there was no change in growth-hormone concentrations. Clonidine induced a slight increase in blood glucose in healthy subjects and a slight decrease in patients with hypopituitarism. During the test systolic blood-pressure decreased by a mean of 20 mm Hg in the healthy subjects and by 25 mm Hg in the patients with hypopituitarism. The only side-effect observed was drowsiness. Oral administration of clonidine, a well-tolerated drug, seems to be a simple test for of GH reserves in children and adolescents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88610     DOI: 10.1016/s0140-6736(79)90293-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

1.  Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome.

Authors:  S Cannavò; L Bartolone; D Lapa; M Venturino; B Almoto; A Violi; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

2.  Safety of the insulin tolerance test.

Authors:  P J Galloway; E McNeill; W F Paterson; M D C Donaldson
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

Review 3.  Clonidine treatment in children with short stature.

Authors:  S Loche; A Lampis; S G Cella; V Locatelli; E E Müller; C Pintor
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

Review 4.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

5.  Growth hormone deficit in autism.

Authors:  L Ragusa; M Elia; R Scifo
Journal:  J Autism Dev Disord       Date:  1993-06

6.  Growth-hormone releasing factor and clonidine in children with constitutional growth delay. Evidence for defective pituitary growth hormone reserve.

Authors:  C Pintor; R Puggioni; V Fanni; S G Cella; A Villa; V Locatelli; E E Müller
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

7.  Respiratory Depression in Young Prader Willi Syndrome Patients following Clonidine Provocation for Growth Hormone Secretion Testing.

Authors:  Gregory A Hollman; David B Allen; Jens C Eickhoff; Aaron L Carrel
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-28

8.  Occurrence of four types of growth hormone-related dwarfism in Israeli communities.

Authors:  A Adam; Z Josefsberg; A Pertzelan; Z Zadik; J M Chemke; Z Laron
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

9.  Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks.

Authors:  Martha M Rumore
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

10.  Decreased growth hormone (GH) response to oral clonidine in endemic cretinism: effect of L-T3 therapy.

Authors:  M C Martins; M Knobel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.